Morgan Stanley’s Inspire Corporate Bond ETF IBD Stock Holding History

Morgan Stanley’s Portfolio IBD Stock Details IBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.74K	Buy	73 +32	+78%	+$763	﹤0.01%	7433
2026 Q1	$982	Buy	41 +40	+4,000%	+$964	﹤0.01%	7438
2025 Q4	$40	Sell	1 -31	-97%	-$750	﹤0.01%	7931
2025 Q3	$794	Hold	32	–	–	﹤0.01%	7422
2025 Q2	$789	Buy	32 +12	+60%	+$285	﹤0.01%	7356
2025 Q1	$481	Buy	20 +19	+1,900%	+$449	﹤0.01%	7377
2024 Q4	$41	Hold	1	–	–	﹤0.01%	7678
2024 Q3	$25	Buy	+1	New	+$24	﹤0.01%	7779
2024 Q2	–	Sell	-100	Closed	-$2.35K	–	7903
2024 Q1	$2.35K	Buy	+100	New	+$2.35K	﹤0.01%	7043
2023 Q4	–	Sell	-1,909	Closed	-$43.2K	–	7861
2023 Q3	$43.2K	Sell	1,909 -97	-5%	-$2.23K	﹤0.01%	6226
2023 Q2	$46.3K	Buy	2,006 +6	+0.3%	+$139	﹤0.01%	6237
2023 Q1	$46.8K	Hold	2,000	–	–	﹤0.01%	6312
2022 Q4	$46.1K	Hold	2,000	–	–	﹤0.01%	6329
2022 Q3	$45K	Hold	2,000	–	–	﹤0.01%	6454
2022 Q2	$47K	Hold	2,000	–	–	﹤0.01%	6640
2022 Q1	$49K	Buy	+2,000	New	+$50K	﹤0.01%	6715

Other funds holding IBD

Inspire Advisors Meridian, Idaho $1.44B AUM 26.8% 1-Year Est. Return

Faithward Advisors Lancaster, Pennsylvania $819M AUM 41.44% 1-Year Est. Return

CFD

Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

BFS

Bare Financial Services Gap, Pennsylvania $436M AUM 20.22% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.43B AUM 49.04% 1-Year Est. Return

OFS

OneAscent Financial Services Birmingham, Alabama $2.09B AUM 24.1% 1-Year Est. Return

PFG

PAX Financial Group San Antonio, Texas $673M AUM 21.2% 1-Year Est. Return

PAW

Plan A Wealth Lincoln, Nebraska $235M AUM 22.68% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Morgan Stanley's IBD Position: Q2 2026 in Review

Morgan Stanley increased its Inspire Corporate Bond ETF (IBD) stake by 78% in Q2 2026, buying an estimated $763 and bringing the position to 73 shares worth $1.74K. The position accounts for ﹤0.01% of the portfolio, ranked #7433.

Morgan Stanley first reported a position in IBD in Q1 2022 and has held it in 16 quarters since. The position peaked at $49K in Q1 2022. 110 funds tracked by Wall St. Rank hold IBD as of Q2 2026.

Morgan Stanley held 73 shares of Inspire Corporate Bond ETF worth $1.74K as of Q2 2026.
Morgan Stanley bought 32 Inspire Corporate Bond ETF shares in Q2 2026, an estimated $763.
Inspire Corporate Bond ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7433 holding.
Morgan Stanley first reported a position in Inspire Corporate Bond ETF in Q1 2022 and has held it in 16 quarters since.
Morgan Stanley's Inspire Corporate Bond ETF position peaked at $49K in Q1 2022.
110 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.